The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(2-(4-amino-6-(4-phenylbutylamino)-1,3,5-triazin-2-yl)phenyl)methanol ID: ALA4544846
PubChem CID: 155553060
Max Phase: Preclinical
Molecular Formula: C20H23N5O
Molecular Weight: 349.44
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Nc1nc(NCCCCc2ccccc2)nc(-c2ccccc2CO)n1
Standard InChI: InChI=1S/C20H23N5O/c21-19-23-18(17-12-5-4-11-16(17)14-26)24-20(25-19)22-13-7-6-10-15-8-2-1-3-9-15/h1-5,8-9,11-12,26H,6-7,10,13-14H2,(H3,21,22,23,24,25)
Standard InChI Key: RYAMWPNARRKCJJ-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
3.0032 -4.9939 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0021 -5.8134 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7101 -6.2224 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4198 -5.8130 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4169 -4.9903 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7083 -4.5850 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1201 -4.5803 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8296 -4.9880 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.5353 -4.5774 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5326 -3.7593 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.8184 -3.3536 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1157 -3.7665 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.2443 -4.9837 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.9507 -4.5728 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8125 -2.5364 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.7059 -3.7679 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9969 -3.3614 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.6597 -4.9790 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3661 -4.5681 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0752 -4.9744 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7815 -4.5635 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4870 -4.9723 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1929 -4.5620 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1907 -3.7440 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4767 -3.3379 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7737 -3.7504 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 7 1 0
5 7 1 0
9 13 1 0
13 14 1 0
11 15 1 0
6 16 1 0
16 17 1 0
14 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 21 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 349.44Molecular Weight (Monoisotopic): 349.1903AlogP: 3.05#Rotatable Bonds: 8Polar Surface Area: 96.95Molecular Species: NEUTRALHBA: 6HBD: 3#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 4#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 6.49CX LogP: 4.26CX LogD: 4.21Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.54Np Likeness Score: -0.60
References 1. Yu X, Huang XP, Kenakin TP, Slocum ST, Chen X, Martini ML, Liu J, Jin J.. (2019) Design, Synthesis, and Characterization of Ogerin-Based Positive Allosteric Modulators for G Protein-Coupled Receptor 68 (GPR68)., 62 (16): [PMID:31298539 ] [10.1021/acs.jmedchem.9b00869 ]